The global non-metastatic prostate cancer treatment market is a growing sector within the healthcare industry. Driven by an increasing prevalence of prostate cancer, coupled with advancements in diagnostic technologies, this market is poised for significant expansion. Major players in the market are actively investing new therapies and treatment ap